Abstract
Gemfibrozil (CI-719) has proved to be an effective agent in reducing the plasma triglyceride levels in experimental animals and in patients with endogenous hypertriglyceridaemia. We have confirmed these findings.
MeSH terms
-
Apoproteins / metabolism
-
Fatty Acids, Nonesterified / metabolism
-
Humans
-
Hypolipidemic Agents / pharmacology*
-
Kinetics
-
Lipid Metabolism*
-
Lipoproteins, LDL / metabolism
-
Lipoproteins, VLDL / metabolism
-
Time Factors
-
Triglycerides / blood
-
Valerates / pharmacology*
-
Xylenes / pharmacology*
Substances
-
Apoproteins
-
Fatty Acids, Nonesterified
-
Hypolipidemic Agents
-
Lipoproteins, LDL
-
Lipoproteins, VLDL
-
Triglycerides
-
Valerates
-
Xylenes